Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

Delayed Data
As of Jul 22
 -0.09 / -0.29%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 15 analysts offering 12-month price forecasts for Impax Laboratories Inc have a median target of 34.00, with a high estimate of 48.00 and a low estimate of 25.00. The median estimate represents a +11.70% increase from the last price of 30.44.

Analyst Recommendations

The current consensus among 16 polled investment analysts is to Hold stock in Impax Laboratories Inc. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jul 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -23.65%
Growthannually 22.69%


Growthquarterly -0.24%
Growthannually 15.78%
Key to the earnings and sales forecast charts.